Mutations in protein N-arginine methyltransferases are not the cause of FTLD-FUS

Neurobiology of Aging

Volumn 34, Issue 9, 2013, Pages 2235.e11-2235.e13

  Ravenscroft, Thomas A ^a   Baker, Matt C ^a   Rutherford, Nicola J ^a   Neumann, Manuela ^b,c   Mackenzie, Ian R ^d   Josephs, Keith A ^e   Boeve, Bradley F ^e   Petersen, Ronald ^e   Halliday, Glenda M ^f,j   Kril, Jillian ^g   van Swieten, John C ^h,k   Seeley, William W ⁱ   Dickson, Dennis W ^a   Rademakers, Rosa ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e MAYO CLINIC   (United States)

^f NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF NEW SOUTH WALES   (Australia)

^k VU UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

FET proteins; Frontotemporal lobar degeneration; FUS; PRMT1; PRMT3; PRMT8; Protein N arginine methyltransferase

Indexed keywords

FUSED IN SARCOMA PROTEIN; MESSENGER RNA; SYNAPTOPHYSIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FRONTOTEMPORAL DEMENTIA; GENE; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN N ARGININE METHYLTRANSFERASE 1 GENE; PROTEIN N ARGININE METHYLTRANSFERASE 3 GENE; PROTEIN N ARGININE METHYLTRANSFERASE 8 GENE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

EID: 84878943012     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.04.004     Document Type: Article

References (19)

1. Chook Y.M., Suel K.E. Nuclear import by karyopherin-beta s: recognition and inhibition. Biochim. Biophys. Acta. Mol. Cell Res. 2011, 1813:1593-1606.
2. Dormann D., Madl T., Valori C.F., Bentmann E., Tahirovic S., Abou-Ajram C., Kremmer E., Ansorge O., Mackenzie I.R.A., Neumann M., Haass C. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS. EMBO J. 2012, 31:4258-4275.
3. Jobert L., Argentini M., Tora L. PRMT1 mediated methylation of TAF15 is required for its positive gene regulatory function. Exp. Cell Res. 2009, 315:1273-1286.
4. Josephs K.A., Lin W.L., Ahmed Z., Stroh D.A., Graff-Radford N.R., Dickson D.W. Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions. Acta Neuropathologica. 2008, 116:159-167.
5. Kim J.D., Kako K., Kakiuchi M., Park G.G., Fukamizu A. EWS is a substrate of type I protein arginine methyltransferase, PRMT8. Int. J. Mol. Med. 2008, 22:309-315.
6. Kwiatkowski T.J., Bosco D.A., LeClerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., Valdmanis P., Rouleau G.A., Hosler B.A., Cortelli P., de Jong P.J., Yoshinaga Y., Haines J.L., Pericak-Vance M.A., Yan J., Ticozzi N., Siddique T., McKenna-Yasek D., Sapp P.C., Horvitz H.R., Landers J.E., Brown R.H. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323:1205-1208.
7. Mackenzie I.R.A., Neumann M. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis. Brain Res. 2012, 1462:40-43.
8. Mackenzie I.R.A., Rademakers R., Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurology 2010, 9:995-1007.
9. Neumann M., Bentmann E., Dormann D., Jawaid A., DeJesus-Hernandez M., Ansorge O., Roeber S., Kretzschmar H.A., Munoz D.G., Kusaka H., Yokota O., Ang L.C., Bilbao J., Rademakers R., Haass C., Mackenzie I.R.A. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain 2011, 134:2595-2609.
10. Neumann M., Valori C.F., Ansorge O., Kretzschmar H.A., Munoz D.G., Kusaka H., Yokota O., Ishihara K., Ang L.C., Bilbao J.M., Mackenzie I.R.A. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations. Acta Neuropathol. 2012, 124:705-716.
11. Neumann M., Rademakers R., Roeber S., Baker M., Kretzschmar H.A., Mackenzie I.R.A. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 2009, 132:2922-2931.
12. Pahlich S., Bschir K., Chiavi C., Belyanskaya L., Gehring H. Different methylation characteristics of protein arginine methyltransferase 1 and 3 toward the Ewing sarcoma protein and a peptide. Proteins Struct. Function Bioinform. 2005, 61:164-175.
13. Rohrer J.D., Guerreiro R., Vandrovcova J., Uphill J., Reiman D., Beck J., Isaacs A.M., Authier A., Ferrari R., Fox N.C., Mackenzie I.R.A., Warren J.D., de Silva R., Holton J., Revesz T., Hardy J., Mead S., Rossor M.N. The heritability and genetics of frontotemporal lobar degeneration. Neurology 2009, 73:1451-1456.
14. Rohrer J.D., Lashley T., Holton J., Revesz T., Urwin H., Isaacs A.M., Fox N.C., Rossor M.N., Warren J. The clinical and neuroanatomical phenotype of FUS associated frontotemporal lobar degeneration. J. Neurol. Nurosur. Ps. 2011, 82:1405-1407.
15. Seelaar H., Klijnsma K.Y., de Koning I., van der Lugt A., Chiu W.Z., Azmani A., Rozemuller A.J.M., Swieten J.C. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. J. Neurol. 2010, 257:747-753.
16. Snowden J.S., Hu Q., Rollinson S., Halliwell N., Robinson A., Davidson Y.S., Momeni P., Baborie A., Griffiths T.D., Jaros E., Perry R.H., Richardson A., Pickering-Brown S.M., Neary D., Mann D.M.A. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene. Acta Neuropathol. 2011, 122:99-110.
17. Tradewell M.L., Yu Z.B., Tibshirani M., Boulanger M.C., Durham H.D., Richard S. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations. Hum Mol Genet. 2012, 21:136-149.
18. Urwin H., Josephs K.A., Rohrer J.D., Mackenzie I.R., Neumann M., Authier A., Seelaar H., Van Swieten J.C., Brown J.M., Johannsen P., Nielsen J.E., Holm I.E., Dickson D.W., Rademakers R., Graff-Radford N.R., Parisi J.E., Petersen R.C., Hatanpaa K.J., White C.L., Weiner M.F., Geser F., Van Deerlin V.M., Trojanowski J.Q., Miller B.L., Seeley W.W., van der Zee J., Kumar-Singh S., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Bigio E.H., Deng H.X., Halliday G.M., Kril J.J., Munoz D.G., Mann D.M., Pickering-Brown S.M., Doodeman V., Adamson G., Ghazi-Noori S., Fisher E.M.C., Holton J.L., Revesz T., Rossor M.N., Collinge J., Mead S., Isaacs A.M., Consortium F.R. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 2010, 120:33-41.
19. Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K.L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P.N., Blair I.P., Nicholson G., de Belleroche J., Gallo J.M., Miller C.C., Shaw C.E. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.